Therapeutic Expertise: Oncology

Increased life expectancy, lifestyle changes, and migration to urban areas with better access to healthcare has helped the diagnosis and treatment of cancer in India to increase significantly. According to the American Cancer Society, there are approximately 2.5 million patients currently suffering from a form of cancer in India, and approximately 800,000 cases were diagnosed in 2000. More than 70% of India’s cancer patients receive late diagnoses, when symptoms are advanced and treatment is less effective. With the number of cases steadily increasing, physicians are working to find alternative treatments and a cure for the various forms of cancer prevalent in India.

 

Patient Access

India’s extensive disease and treatment-naïve populations coupled with our network of research sites provide substantial patient access for FDA- regulated global trials. ISS is affiliated with more than 125 oncologists looking to conduct additional clinical trials for oncology and cancer-related indications. Our oncologists treat an average of 500 cases per month, with a steady increase of new patients.

population chart

Oncology Experience

Indication Phase Subjects Enrolled Enrollment Result Retention Rate
Adenocarcinoma
I
18
On-time
95%
Breast Carcinoma
II
22
On-time
92%
Pancreatic Carcinoma
III
16
Ahead of Schedule
97%
Head & Neck Carcinoma
II
26
Ahead of Schedule
89%
Small Cell Lung Cancer
III
24
Ongoing
100%
Metastatic Breast Cancer
II
2/35
within 1 week
Ongoing
100%
Recurrent Head and Neck Cancer
I / III
100 pts / 7 sites
TBD Initiating
TBD Initiating
Multiple Indications
(G-CSF support therapy)
III
100
On-time
94%
Multiple Indications
(Gm- CSF support therapy)
III
100
On-time
96%